DHA SUPPLEMENTS MARKET ANALYSIS

Dha Supplements MarketSize and Trends

The global DHA supplements market is estimated to be valued at US$ 1,385.8 million in 2021 and is expected to exhibit a CAGR of 7.0% during the forecast period (2021-2028).

Increasing product launches is expected to drive the market growth during the forecast period.

Increasing product launches are expected to drive the growth of the global DHA supplements market over the forecast period. For instance, in April 2017, Anlit, a company that produces high-quality dietary supplements, launched a high DHA+EPA Omega-3 supplement in a single, fish-shaped chew supplement for children and adults. This product offers a friendly and tasty alternative, with no unpleasant after-taste, making it a good healthy option for children.

The increasing use of DHA supplements in treating cardiovascular diseases, brain disorders, and others is expected to drive the market growth during the forecast period.

The increased use of DHA supplements in treating various cardiovascular diseases, brain disorders, and others is expected to drive the market growth during the forecast period. For instance, according to an article published by Healthline Media, a provider of health information, in May 2019, DHA is extremely important for brain tissue growth and function, especially during infancy and development. The same source stated that low levels of DHA are linked with various diseases, including brain disorders such as Alzheimer’s disease. This article stated that patients with Alzheimer’s disease generally have lower amounts of DHA in their brains and livers.

Figure 1.Global DHA Supplements Market Share (%) in Terms of Value, by Source, 2021

Figure 2.Global DHA Supplements Market Share (%), by Application, 2021

Global DHA Supplements Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization  declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic brought attention to the importance and the potential benefits of dietary supplements, including DHA, in fighting the COVID-19 infection. For instance, according to an article published by the American Society for Microbiology in May 2021, preliminary evidence from banked blood samples of 100 COVID-19 patients suggests that patients with a higher omega-3 index, a measure of the amount of EPA and DHA in red blood cells, had a lower risk of death due to COVID-19. This study was carried out by the researchers of the Fatty Acid Research Institute (FARI), a non-profit research and education foundation, and collaborators at Cedars-Sinai Medical Center, a nonprofit academic healthcare organization, in Los Angeles and Orange County, California. The same source stated that considering that there is significant evidence that n-3 fatty acids and other fish oil-derived lipids possess anti-inflammatory properties and antithrombotic properties, they may have therapeutic value against the prothrombotic complications associated with COVID-19.

Therefore, the increasing research on the potential uses of DHA supplements in treating or reducing complications associated with viral infections such as COVID-19, and others, is expected to increase the demand for DHA supplements and thereby drive the global DHA supplements market growth over the forecast period.